Patent ID: 8188103

Claim:
A compound of the formula (I) or an N-oxide form, pharmaceutically acceptable addition salt and a stereoisomer thereof, wherein the dotted line represents an optional bond; X is >N—, >CH— or >CR 2 — wherein R 2 is aminocarbonyl; R 1 is hydrogen, halo, C 1-6 alkyloxy or C 1-6 alkyl; R 3 is hydrogen, or C 1-6 alkyloxy; Z is a radical selected from wherein each R 5 , R 6 , R 7 and R 8 is independently selected from hydrogen, halo, amino, C 1-6 alkyl or C 1-6 alkyloxy; or R 7 and R 8 taken together may form a bivalent radical of formula —CH 2 —CR 9 2 —O— (c-1), —(CH 2 ) 3 —O— (c-2), —O—(CH 2 ) 2 —O— (c-3) or —CH═CH—CH═CH— (c-4) wherein each R 9 is independently selected from hydrogen or C 1-6 alkyl; and L is a bivalent radical selected from —C(O)—NH—, —C(O)—C 1-6 alkanediyl- or —C(O)—O—C 1-6 alkanediyl-; or L can be a direct bond when X is >CR 2 — or when Z is a radical of formula (b-11).